Table 3 Association between the risk of liver cirrhosis development and diabetes duration, diabetes treatment, diabetes complications, and other variables in diabetes patients.
Variables | Liver cirrhosis N = 45 | CHC-only N = 62 | P # | AOR (95% CI)* | P** |
|---|---|---|---|---|---|
Sex | 0.065 | 0.415 (0.178–0.969) | 0.042 | ||
Female, N (%) | 27 (60.0) | 26 (41.9) | |||
Male, N (%) | 18 (40.0) | 36 (58.1) | |||
Age | 0.554 | — | — | ||
<50 | 6 (13.3) | 6 (9.7) | |||
≥50 | 39 (86.7) | 56 (90.3) | |||
Duration of diabetes | 0.873 | — | - | ||
≤5 years, N (%) | 34 (75.6) | 46 (74.2) | |||
>5 years, N (%) | 11 (24.4) | 16 (25.8) | |||
Diabetes treatment | 0.836 | — | — | ||
No, N (%) | 22 (48.9) | 30 (48.4) | |||
single drug, N (%) | 23 (51.1) | 31 (50.0) | |||
multiple drugs, N (%) | 0 | 1 (1.6) | |||
Diabetic retinopathy | 0.023 | — | — | ||
No, N (%) | 44 (97.8) | 52 (83.9) | |||
Yes, N (%) | 1 (2.2) | 10 (16.1) | |||
Diabetic neuropathy | 1.000 | — | — | ||
No, N (%) | 45 (100.0) | 61 (98.4) | |||
Yes, N (%) | 0 (0.0) | 1 (1.6) | |||
Diabetic nephropathy | 0.571 | — | — | ||
No, N (%) | 43 (95.6) | 61 (98.4) | |||
Yes, N (%) | 2 (4.4) | 1 (1.6) | |||
Triglycerides | 0.017 | 0.268 (0.079–0.910) | 0.035 | ||
≤1.8 mmol/L, N (%) | 41 (91.1) | 45 (72.6) | |||
>1.8 mmol/L, N (%) | 4 (8.9) | 17 (27.4) | |||
Cholesterol | 1.000 | — | — | ||
≤6.0 mmol/L, N (%) | 42 (93.3) | 58 (93.5) | |||
>6.0 mmol/L, N (%) | 3 (6.7) | 4 (6.5) | |||
Gallstones | 0.004 | 4.938 (1.524–15.998) | 0.008 | ||
No, N (%) | 32 (71.1) | 57 (91.9) | |||
Yes, N (%) | 13 (28.9) | 5 (8.1) |
